Boomerang Medical is a women-led bioelectronic medical company that was granted breakthrough device designation from the FDA for its bioelectronic IBD solution.
“The most fascinating aspect of this study is the possibility of managing IBD simply by stimulating the patient’s autonomic system to release anti-inflammatory mediators,” Marco Zoccali, MD, a principal investigator for the trial at Columbia, said in an April 17 press release.
